Loading company…
Seqstant develops software for pathogen analysis and metagenomic diagnostics in laboratories.
Based in Teltow, Germany, Seqstant develops software for pathogen analysis and metagenomic diagnostics. Its LiveGene product automates sequencing analysis from device startup through report generation. In November 2023, it raised EUR 1.8 million in seed funding led by Brandenburg Kapital, with SB21, Impact Investment Group, VLC Venture League, and HPI Seed Fund participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in